Your Health, We Care
Another NameLuciLena,Revlimid,来那度胺
IndicationsIt is used for the treatment of various hematological diseases such as multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma.
Reg No.12 L 1284/24
Inspection NO.3154-24
Lenalidomide produced by Lucius Pharmaceuticals has a relatively balanced performance in terms of efficacy and safety, providing patients with a reliable-quality treatment option.
Here is a brief summary of the key information about lenalidomide:
The main active ingredient is lenalidomide, which is a thalidomide analog.
It is indicated for adult patients with multiple myeloma, specific types of myelodysplastic syndromes, lymphoma, and other related conditions.
It is administered orally once daily. The dosage varies depending on the indication and treatment phase, with a common range of 5mg to 25mg.
It is contraindicated in pregnant women, not recommended for use during lactation. Dosage adjustment is required for patients with renal impairment, and caution should be exercised when administering the drug to elderly patients.
Hematological toxicity may occur in cases of drug overdose, and symptomatic and supportive treatment is required.
The medicine should be stored at room temperature, away from moisture and high temperatures.
Pharmacokinetic data show that it has good oral absorption, with a half-life of approximately 3–5 hours, and is mainly excreted via the kidneys.
FDA，2023.03
